BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aslani A, Gill AJ, Roach PJ, Allen BJ, Smith RC. Preoperative body composition is influenced by the stage of operable pancreatic adenocarcinoma but does not predict survival after Whipple's procedure. HPB (Oxford) 2010;12:325-33. [PMID: 20590908 DOI: 10.1111/j.1477-2574.2010.00171.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Gruber ES, Jomrich G, Tamandl D, Gnant M, Schindl M, Sahora K. Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma. PLoS One 2019;14:e0215915. [PMID: 31059520 DOI: 10.1371/journal.pone.0215915] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
2 Fearon KC, Baracos VE. Cachexia in pancreatic cancer: new treatment options and measures of success. HPB (Oxford). 2010;12:323-324. [PMID: 20590907 DOI: 10.1111/j.1477-2574.2010.00178.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
3 Ozola Zalite I, Zykus R, Francisco Gonzalez M, Saygili F, Pukitis A, Gaujoux S, Charnley RM, Lyadov V. Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review. Pancreatology. 2015;15:19-24. [PMID: 25524484 DOI: 10.1016/j.pan.2014.11.006] [Cited by in Crossref: 89] [Cited by in F6Publishing: 77] [Article Influence: 11.1] [Reference Citation Analysis]
4 Jachnis A, Słodkowski MT. The Relationship between Nutritional Status and Body Composition with Clinical Parameters, Tumor Stage, CA19-9, CEA Levels in Patients with Pancreatic and Periampullary Tumors. Curr Oncol 2021;28:4805-20. [PMID: 34898583 DOI: 10.3390/curroncol28060406] [Reference Citation Analysis]
5 Joglekar S, Nau PN, Mezhir JJ. The impact of sarcopenia on survival and complications in surgical oncology: A review of the current literature. J Surg Oncol. 2015;112:503-509. [PMID: 26310812 DOI: 10.1002/jso.24025] [Cited by in Crossref: 91] [Cited by in F6Publishing: 89] [Article Influence: 13.0] [Reference Citation Analysis]
6 Bundred J, Kamarajah SK, Roberts KJ. Body composition assessment and sarcopenia in patients with pancreatic cancer: a systematic review and meta-analysis. HPB 2019;21:1603-12. [DOI: 10.1016/j.hpb.2019.05.018] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
7 Onesti JK, Wright GP, Kenning SE, Tierney MT, Davis AT, Doherty MG, Chung MH. Sarcopenia and survival in patients undergoing pancreatic resection. Pancreatology. 2016;16:284-289. [PMID: 26876798 DOI: 10.1016/j.pan.2016.01.009] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
8 Hou YC, Wang CJ, Chao YJ, Chen HY, Wang HC, Tung HL, Lin JT, Shan YS. Elevated Serum Interleukin-8 Level Correlates with Cancer-Related Cachexia and Sarcopenia: An Indicator for Pancreatic Cancer Outcomes. J Clin Med 2018;7:E502. [PMID: 30513776 DOI: 10.3390/jcm7120502] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]
9 Muircroft W. An Australasian perspective on the curative treatment of patients with pancreatic cancer, supportive care, and future directions for management. Ecancermedicalscience 2016;10:700. [PMID: 28105071 DOI: 10.3332/ecancer.2016.700] [Reference Citation Analysis]
10 Mantzorou M, Koutelidakis A, Theocharis S, Giaginis C. Clinical Value of Nutritional Status in Cancer: What is its Impact and how it Affects Disease Progression and Prognosis? Nutr Cancer. 2017;69:1151-1176. [PMID: 29083236 DOI: 10.1080/01635581.2017.1367947] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 9.6] [Reference Citation Analysis]
11 Xue A, Chang JW, Chung L, Samra J, Hugh T, Gill A, Butturini G, Baxter RC, Smith RC. Serum apolipoprotein C-II is prognostic for survival after pancreatic resection for adenocarcinoma. Br J Cancer. 2012;107:1883-1891. [PMID: 23169340 DOI: 10.1038/bjc.2012.458] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]